Co-Authors
This is a "connection" page, showing publications co-authored by SHERISE DESIREE FERGUSON and IAN E MCCUTCHEON.
Connection Strength
2.342
-
The surgical treatment of tumors of the fourth ventricle: a single-institution experience. J Neurosurg. 2018 02; 128(2):339-351.
Score: 0.587
-
Fatal juvenile xanthogranuloma presenting as a sellar lesion: case report and literature review. Childs Nerv Syst. 2015 May; 31(5):777-84.
Score: 0.499
-
Ventriculoperitoneal shunting with an on-off valve for patients with leptomeningeal metastases and intracranial hypertension. Neurooncol Pract. 2024 Feb; 11(1):56-63.
Score: 0.228
-
Changes in outcomes and factors associated with survival in melanoma patients with brain metastases. Neuro Oncol. 2023 Jul 06; 25(7):1310-1320.
Score: 0.226
-
Predictors of survival in metastatic melanoma patients with leptomeningeal disease (LMD). J Neurooncol. 2019 May; 142(3):499-509.
Score: 0.167
-
Neurosurgical management of brain metastases. Clin Exp Metastasis. 2017 10; 34(6-7):377-389.
Score: 0.151
-
Author Correction: Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results. Nat Med. 2024 Jun; 30(6):1787.
Score: 0.060
-
Response of treatment-naive brain metastases to stereotactic radiosurgery. Nat Commun. 2024 May 02; 15(1):3728.
Score: 0.060
-
Survival and treatment outcomes in patients with leptomeningeal disease from metastatic melanoma. Neurooncol Pract. 2024 Aug; 11(4):452-463.
Score: 0.059
-
Subependymomas of the fourth ventricle: To operate or not to operate? J Clin Neurosci. 2023 Dec; 118:147-152.
Score: 0.058
-
Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results. Nat Med. 2023 04; 29(4):898-905.
Score: 0.055
-
Long term outcomes following surgery for pineal region tumors. J Neurooncol. 2022 Feb; 156(3):491-498.
Score: 0.051
-
Circumferential sulcus-guided resection technique for improved outcomes of low-grade gliomas. J Neurosurg. 2022 Oct 01; 137(4):1015-1025.
Score: 0.051
-
Window-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophages. Neuro Oncol. 2020 04 15; 22(4):539-549.
Score: 0.045
-
Perilesional Resection of Glioblastoma Is Independently Associated With Improved Outcomes. Neurosurgery. 2020 01 01; 86(1):112-121.
Score: 0.044